Stellar-002: XL-092 +/- immunotherapy for genitourinary cancers

Clinical Trial Grant

Duke Scholars

Principal Investigator Daniel James George Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Exelixis, Inc

Start Date

November 14, 2022

End Date

October 31, 2027

Administered By

Duke Cancer Institute

Awarded By

Exelixis, Inc

Start Date

November 14, 2022

End Date

October 31, 2027